KRT10-AS1 (Gene)

Entrez:147184

Description:KRT10 antisense RNA 1

Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View KRT10-AS1's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with KRT10-AS1.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using KRT10-AS1.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for KRT10-AS1.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with KRT10-AS1.

Results found

Linked to

	Label	Description
	GSE77108 saha 4 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE119978 GSE180930 cisplatin 3 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE179235 MEK NRAS inhibition 2 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE173116 GSE173118 ML-7 3 v 10 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE119345 bexarotene T cell 0 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE158834 ADIPOR2 knockout HEK293 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE261563 CX-5461 3 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE147815 GSE147817 LSD1 inhibition McCoy 2 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE228261 FDX1 overexpression WSU-DLCL2 Elesclomol 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE228261 elesclomol WSU-DLCL2 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS

GSE77108 saha 4 v 7 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE119978 GSE180930 cisplatin 3 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE179235 MEK NRAS inhibition 2 v 6 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE173116 GSE173118 ML-7 3 v 10 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE119345 bexarotene T cell 0 v 3 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE158834 ADIPOR2 knockout HEK293 1 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE261563 CX-5461 3 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE147815 GSE147817 LSD1 inhibition McCoy 2 v 3 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE228261 FDX1 overexpression WSU-DLCL2 Elesclomol 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE228261 elesclomol WSU-DLCL2 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.